Income Taxes (Details) - Schedule of deferred tax assets - USD ($) |
Dec. 31, 2020 |
Dec. 31, 2019 |
|---|---|---|
| Current: | ||
| Accrued expenses | $ 464,042 | $ 223,712 |
| Stock compensation | 869,815 | 838,753 |
| Net operating loss carryforward | 16,165,927 | 11,978,595 |
| Research and development credit carry forward | 548,983 | 367,261 |
| Total deferred tax assets | 18,048,767 | 13,408,321 |
| Valuation allowance | (18,048,767) | (13,408,321) |
| Deferred tax asset, net of valuation allowance |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|